Acute pulmonary embolism.

Area of Science:

• Cardiology
• Oncology
• Hematology

Background:

• Venous thromboembolism (VTE) is a leading cause of cardiovascular death and a significant concern in hospitalized cancer patients.
• Controversy persists regarding the efficacy and safety of thrombolytic therapy for acute pulmonary embolism (PE), particularly in patients with malignancy.
• Existing research on thrombolytic therapy for PE has largely excluded patients with active or recent cancer.

Observation:

• A case of a patient in remission from breast cancer presenting with symptomatic pulmonary emboli is detailed.
• The patient's presentation, the medical management strategy employed, and the subsequent treatment consequences are described.
• The case highlights the complexities of managing acute PE in a patient with a history of malignancy.

Findings:

• Thrombolytic therapy was administered to a cancer patient with symptomatic pulmonary embolism.
• The presentation, management, and outcomes associated with this treatment approach were observed.
• The case provides insights into the potential benefits and risks of thrombolysis in this specific patient population.

Implications:

• This case contributes to the limited literature on thrombolytic therapy for acute pulmonary embolism in cancer patients.
• It underscores the need for further research to clarify the role of thrombolysis in managing PE in patients with a history of malignancy.
• Understanding treatment outcomes in such cases can inform clinical decision-making and improve patient care for VTE in oncology settings.